, des HTA gravidiques pour 5% de faux positifs

L. Duley, The global impact of pre-eclampsia and eclampsia, Semin Perinatol

K. S. Khan, D. Wojdyla, L. Say, and A. M. Gülmezoglu, Van Look PFA. WHO analysis of causes of maternal death: a systematic review, Lancet, vol.367, pp.1066-74, 2006.

J. Chang, L. D. Elam-evans, C. J. Berg, J. Herndon, L. Flowers et al., Pregnancyrelated mortality surveillance--United States, Morb Mortal Wkly Rep Surveill Summ Wash DC, vol.52, pp.1-8, 2002.

E. Steegers, P. Von-dadelszen, J. J. Duvekot, and R. Pijnenborg, Pre-eclampsia, Lancet, vol.376, pp.631-675, 2010.

S. P. Chauhan, J. Cole, M. Sanderson, E. F. Magann, and J. A. Scardo, Suspicion of intrauterine growth restriction: Use of abdominal circumference alone or estimated fetal weight below 10%

, J Matern-Fetal Neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet, vol.19, pp.557-62, 2006.

B. Eskenazi, L. Fenster, and S. Sidney, A multivariate analysis of risk factors for preeclampsia, JAMA J Am Med Assoc, vol.266, pp.237-278, 1991.

K. Duckitt and D. Harrington, Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies, BMJ, vol.330, p.565, 2005.

S. E. Maynard, J. Min, J. Merchan, K. Lim, J. Li et al., Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia, J Clin Invest, vol.111, pp.649-58, 2003.

S. Venkatesha, M. Toporsian, C. Lam, J. Hanai, T. Mammoto et al., Soluble endoglin contributes to the pathogenesis of preeclampsia, Nat Med, vol.12, pp.642-651, 2006.

, Angiogenic growth factor levels in maternal and fetal blood: correlation with Doppler ultrasound parameters in pregnancies complicated by pre-eclampsia and intrauterine growth restriction, Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol, vol.29, pp.407-420, 2007.

M. Widmer, J. Villar, A. Benigni, A. Conde-agudelo, S. A. Karumanchi et al.,

, Mapping the theories of preeclampsia and the role of angiogenic factors: a systematic review

, Obstet Gynecol, vol.109, pp.168-80, 2007.

J. Espinoza, T. Chaiworapongsa, R. Romero, Y. M. Kim, G. J. Kim et al.,

, Unexplained fetal death: another anti-angiogenic state, J Matern-Fetal Neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet, vol.20, pp.495-507, 2007.

A. M. Germain, M. C. Romanik, I. Guerra, S. Solari, M. S. Reyes et al.,

, Endothelial dysfunction: a link among preeclampsia, recurrent pregnancy loss, and future cardiovascular events?, Hypertension, vol.49, pp.90-95, 2007.

S. Venkatesha, M. Toporsian, C. Lam, J. Hanai, T. Mammoto et al., Soluble endoglin contributes to the pathogenesis of preeclampsia, Nat Med, vol.12, pp.642-651, 2006.

R. J. Levine, C. Lam, C. Qian, K. F. Yu, S. E. Maynard et al., Soluble endoglin and other circulating antiangiogenic factors in preeclampsia, N Engl J Med, vol.355, pp.992-1005, 2006.

H. Stepan, T. Krämer, and R. Faber, Maternal plasma concentrations of soluble endoglin in pregnancies with intrauterine growth restriction, J Clin Endocrinol Metab, vol.92, pp.2831-2835, 2007.

A. G. Moore, H. Young, J. M. Keller, L. R. Ojo, J. Yan et al., Angiogenic biomarkers for prediction of maternal and neonatal complications in suspected preeclampsia

. Matern-fetal, Neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet, vol.25, pp.2651-2658, 2012.

R. W. Powers, A. Jeyabalan, R. G. Clifton, P. Van-dorsten, J. C. Hauth et al.,

, Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies, PloS One, vol.5, p.13263, 2010.

, Échographie en pratique obstétricale -9782294731730

, ebooks, revues et traités EMC pour toutes spécialités médicales et paramédicales 20

C. R. Harman and A. A. Baschat, Comprehensive assessment of fetal wellbeing: which Doppler tests should be performed?, Curr Opin Obstet Gynecol, vol.15, pp.147-57, 2003.

J. S. Cnossen, R. K. Morris, G. Riet, . Ter, B. Mol et al.,

, Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis, Can Med Assoc J, vol.178, pp.701-712, 2008.

L. Velauthar, M. N. Plana, M. Kalidindi, J. Zamora, B. Thilaganathan et al., Firsttrimester uterine artery Doppler and adverse pregnancy outcome: a meta-analysis involving 55,974 women, Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol, vol.43, pp.500-507, 2014.

P. I. Gómez-arriaga, I. Herraiz, E. A. López-jiménez, E. Gómez-montes, B. Denk et al.,

A. , Uterine artery Doppler and sFlt-1/PlGF ratio: usefulness in diagnosis of pre-eclampsia

D. Schlembach, W. Wallner, R. Sengenberger, E. Stiegler, M. Mörtl et al., Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol, vol.41, pp.530-537, 2013.

M. A. Brown, M. D. Lindheimer, M. De-swiet, A. Van-assche, and J. M. Moutquin, The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP), Hypertens Pregnancy Off J Int Soc Study Hypertens Pregnancy, vol.20, 2001.

Y. Yu, L. Shen, and M. Zhong,

, Zhonghua Fu Chan Ke Za Zhi, vol.39, pp.793-799, 2004.

M. Torricelli, F. M. Reis, and P. Florio, Low-molecular-weight heparin improves the performance of uterine artery Doppler velocimetry to predict preeclampsia and small-forgestational age infant in women with gestational hypertension, Ultrasound Med Biol, vol.32, pp.1431-1436, 2006.

, Retard de croissance intra-utérin : recommandations pour la pratique clinique -Texte court, J Gynécologie Obstétrique Biol Reprod, vol.42, pp.1018-1043, 2013.

, 134: fetal growth restriction, Obstet Gynecol, vol.121, pp.1122-1155, 2013.

F. P. Hadlock, R. B. Harrist, R. S. Sharman, R. L. Deter, and S. K. Park, Estimation of fetal weight with the use of head, body, and femur measurements--a prospective study, Am J Obstet Gynecol, vol.151, pp.333-340, 1985.

K. W. Fong, A. Ohlsson, and M. E. Hannah, Prediction of perinatal outcome in fetuses suspected to have intrauterine growth restriction: Doppler US study of fetal cerebral, renal, and umbilical arteries, Radiology, vol.213, pp.681-690, 1999.

B. Blondel, K. Supernant, C. Du-mazaubrun, and G. Bréart,

P. Enquêtes-nationales, Trends in perinatal health in metropolitan France between 1995 and 2003: results from the National Perinatal Surveys

, J Gynécologie Obstétrique Biol Reprod, vol.35, pp.373-87, 2006.

R. Resnik, Intrauterine growth restriction, Obstet Gynecol, vol.99, pp.490-496, 2002.

D. Getahun, C. V. Ananth, and W. L. Kinzler, Risk factors for antepartum and intrapartum stillbirth: a population-based study, Am J Obstet Gynecol, vol.196, pp.499-507, 2007.

E. K. Pallotto and H. W. Kilbride, Perinatal outcome and later implications of intrauterine growth restriction, Clin Obstet Gynecol, vol.49, pp.257-69, 2006.

D. Barker, Adult consequences of fetal growth restriction, Clin Obstet Gynecol, vol.49, pp.270-83, 2006.

J. Unterscheider, S. Daly, and M. P. Geary, Optimizing the definition of intrauterine growth restriction: the multicenter prospective PORTO Study, Am J Obstet Gynecol, vol.208, pp.290-291, 2013.

S. Bower, J. Kingdom, and S. Campbell, Objective and subjective assessment of abnormal uterine artery Doppler flow velocity waveforms, Ultrasound Obstet Gynecol, vol.12, pp.260-264, 1998.

J. S. Cnossen, R. K. Morris, and G. Ter-riet, Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis, CMAJ Can Med Assoc J J Assoc Medicale Can, vol.178, pp.701-712, 2008.

J. Miller, S. Turan, and A. A. Baschat, Fetal growth restriction, Semin Perinatol, vol.32, pp.274-80, 2008.
URL : https://hal.archives-ouvertes.fr/pasteur-01351893

N. Hendrix and V. Berghella, Non-placental causes of intrauterine growth restriction, Semin Perinatol, vol.32, pp.161-166, 2008.

C. W. Redman, Current topic: pre-eclampsia and the placenta, Placenta, vol.12, pp.301-309, 1991.

S. L. Janes, P. M. Kyle, C. Redman, and A. H. Goodall, Flow cytometric detection of activated platelets in pregnant women prior to the development of pre-eclampsia, Thromb Haemost, vol.74, pp.1059-63, 1995.

G. Masotti, G. Galanti, L. Poggesi, R. Abbate, N. Serneri et al., Differential inhibition of prostacyclin production and platelet aggregation by aspirin, Lancet, vol.2, pp.1213-1220, 1979.

F. Bussolino, C. Benedetto, M. Massobrio, and G. Camussi, Maternal vascular prostacyclin activity in pre-eclampsia, Lancet, vol.2, p.702, 1980.

D. Schlembach, W. Wallner, and R. Sengenberger, Angiogenic growth factor levels in maternal and fetal blood: correlation with Doppler ultrasound parameters in pregnancies complicated by pre-eclampsia and intrauterine growth restriction, Ultrasound Obstet Gynecol, vol.29, pp.407-420, 2007.

H. Stepan, T. Krämer, R. Faber, V. K. Minior, J. C. Pezzullo et al., Maternal Plasma Concentrations of Soluble Endoglin in Pregnancies with Intrauterine Growth Restriction, Salafia CM, vol.92, pp.2831-2835, 2007.

, Intrauterine growth restriction in infants of less than thirty-two weeks' gestation: associated placental pathologic features, Am J Obstet Gynecol, vol.173, pp.1049-57, 1995.

C. M. Salafia, A. K. Charles, and E. M. Maas, Placenta and fetal growth restriction, Clin Obstet Gynecol, vol.49, pp.236-56, 2006.

C. M. Salafia, Placental pathology of fetal growth restriction, Clin Obstet Gynecol, vol.40, pp.740-749, 1997.

G. A. Dekker and B. M. Sibai, Etiology and pathogenesis of preeclampsia: current concepts

, Am J Obstet Gynecol, vol.179, pp.1359-75, 1998.

D. Subtil, P. Goeusse, and F. Puech, Aspirin (100 mg) used for prevention of preeclampsia in nulliparous women: the Essai Régional Aspirine Mère-Enfant study

, BJOG Int J Obstet Gynaecol, vol.110, pp.475-84, 2003.

L. Duley, D. J. Henderson-smart, S. Meher, and J. F. King, Antiplatelet agents for preventing pre-eclampsia and its complications, Cochrane Database Syst Rev Online, p.4659, 2007.

L. M. Askie, L. Duley, D. J. Henderson-smart, and L. A. Stewart, Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data, Lancet, vol.369, pp.1791-1799, 2007.

J. M. Dodd, A. Mcleod, R. C. Windrim, and J. Kingdom, Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction

, Cochrane Database Syst Rev, vol.7, p.6780, 2013.

A. Lausman, F. P. Mccarthy, M. Walker, and J. Kingdom, Screening, diagnosis, and management of intrauterine growth restriction, J Obstet Gynaecol Can JOGC J Obstétrique Gynécologie Can JOGC, vol.34, pp.17-28, 2012.

Y. Yu, L. Shen, H. Zou, Z. Wang, and S. Gong, Heparin for patients with growth restricted fetus: a prospective randomized controlled trial, J Matern-Fetal Neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet, vol.23, pp.980-987, 2010.

D. Subtil, P. Goeusse, and V. Houfflin-debarge, Randomised comparison of uterine artery Doppler and aspirin (100 mg) with placebo in nulliparous women: the Essai Régional Aspirine Mère-Enfant study (Part 2), BJOG Int J Obstet Gynaecol, vol.110, pp.485-91, 2003.

P. Mismetti, S. Laporte, and O. Pellerin, Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial, JAMA, vol.313, pp.1627-1662, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01275317

P. Frappé, A. Buchmuller-cordier, and L. Bertoletti, Annual diagnosis rate of superficial vein thrombosis of the lower limbs: the STEPH community-based study, J Thromb Haemost JTH, vol.12, pp.831-839, 2014.

M. Bonnin, F. Bolandard, F. J. Mercier, J. Bazin, and D. Benhamou,

, Ann Médecine Interne, vol.154, pp.386-91, 2003.

B. J. Sanson, A. W. Lensing, and M. H. Prins, Safety of low-molecular-weight heparin in pregnancy: a systematic review, Thromb Haemost, vol.81, pp.668-72, 1999.

L. Wawrzy?ska, W. Z. Tomkowski, J. Przedlacki, B. Hajduk, and A. Torbicki, Changes in bone density during long-term administration of low-molecular-weight heparins or acenocoumarol for secondary prophylaxis of venous thromboembolism, Pathophysiol Haemost Thromb, vol.33, pp.64-71, 2003.

H. L. Casele and S. A. Laifer, Prospective evaluation of bone density in pregnant women receiving the low molecular weight heparin enoxaparin sodium, J Matern Fetal Med

B. Mol, C. T. Roberts, S. Thangaratinam, L. A. Magee, C. De-groot et al., Lancet Lond Engl, vol.387, pp.999-1011, 2016.

K. S. Khan, D. Wojdyla, L. Say, and A. M. Gülmezoglu, Van Look PFA. WHO analysis of causes of maternal death: a systematic review, Lancet, vol.367, pp.1066-74, 2006.

J. Chang, L. D. Elam-evans, C. J. Berg, J. Herndon, L. Flowers et al., Pregnancyrelated mortality surveillance--United States, Morb Mortal Wkly Rep Surveill Summ Wash DC, vol.52, pp.1-8, 2002.

, Retard de croissance intra-utérin : recommandations pour la pratique clinique -Texte court, J Gynécologie Obstétrique Biol Reprod, vol.42, pp.1018-1043, 2013.

A. Ego, Definitions: small for gestational age and intrauterine growth retardation

, J Gynecol Obstet Biol Reprod (Paris), vol.42, pp.872-94, 2013.

, 134: fetal growth restriction, Obstet Gynecol, vol.121, pp.1122-1155, 2013.

S. Bower, J. Kingdom, and S. Campbell, Objective and subjective assessment of abnormal uterine artery Doppler flow velocity waveforms, Ultrasound Obstet Gynecol, vol.12, pp.260-264, 1998.

J. S. Cnossen, R. K. Morris, G. Ter-riet, B. Mol, J. Van-der-post et al., Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis, CMAJ Can Med Assoc J J Assoc Medicale Can, vol.178, pp.701-712, 2008.

L. J. Salomon and V. Malan,

, J Gynecol Obstet Biol Reprod (Paris), vol.42, pp.929-969, 2013.

W. B. Giles, B. J. Trudinger, and P. J. Baird, Fetal umbilical artery flow velocity waveforms and placental resistance: pathological correlation, Br J Obstet Gynaecol, vol.92, pp.31-39, 1985.

R. J. Morrow, S. L. Adamson, S. B. Bull, and J. W. Ritchie, Effect of placental embolization on the umbilical arterial velocity waveform in fetal sheep, Am J Obstet Gynecol, vol.161, pp.1055-60, 1989.

J. Miller, S. Turan, and A. A. Baschat, Fetal growth restriction, Semin Perinatol, vol.32, pp.274-80, 2008.
URL : https://hal.archives-ouvertes.fr/pasteur-01351893

B. Blondel, K. Supernant, C. Du-mazaubrun, and G. Bréart, pour la Coordination nationale des Enquêtes Nationales Périnatales. [Trends in perinatal health in metropolitan France between, 1995.

, J Gynécologie Obstétrique Biol Reprod, vol.35, pp.373-87, 2006.

R. Resnik, Intrauterine growth restriction, Obstet Gynecol, vol.99, pp.490-496, 2002.

D. Getahun, C. V. Ananth, and W. L. Kinzler, Risk factors for antepartum and intrapartum stillbirth: a population-based study, Am J Obstet Gynecol, vol.196, pp.499-507, 2007.

E. K. Pallotto and H. W. Kilbride, Perinatal outcome and later implications of intrauterine growth restriction, Clin Obstet Gynecol, vol.49, pp.257-69, 2006.

D. Barker, Adult consequences of fetal growth restriction, Clin Obstet Gynecol, vol.49, pp.270-83, 2006.

J. Unterscheider, S. Daly, M. P. Geary, M. M. Kennelly, F. M. Mcauliffe et al., Optimizing the definition of intrauterine growth restriction: the multicenter prospective PORTO Study, Am J Obstet Gynecol, vol.208, pp.290-291, 2013.

E. Lecarpentier, T. Fournier, J. Guibourdenche, and V. Tsatsaris,

, Presse Medicale Paris Fr, vol.45, pp.631-638, 1983.

C. W. Redman, Current topic: pre-eclampsia and the placenta, Placenta, vol.12, pp.301-309, 1991.

I. Brosens, R. Pijnenborg, L. Vercruysse, and R. Romero, The « Great Obstetrical Syndromes » are associated with disorders of deep placentation, Am J Obstet Gynecol, vol.204, pp.193-201, 2011.

T. R. Everett and C. C. Lees, Beyond the placental bed: placental and systemic determinants of the uterine artery Doppler waveform, Placenta, vol.33, pp.893-901, 2012.

C. M. Salafia, V. K. Minior, J. C. Pezzullo, E. J. Popek, T. S. Rosenkrantz et al., Intrauterine growth restriction in infants of less than thirty-two weeks' gestation: associated placental pathologic features, Am J Obstet Gynecol, vol.173, pp.1049-57, 1995.

C. M. Salafia, A. K. Charles, and E. M. Maas, Placenta and fetal growth restriction, Clin Obstet Gynecol, vol.49, pp.236-56, 2006.

C. M. Salafia, Placental pathology of fetal growth restriction, Clin Obstet Gynecol, vol.40, pp.740-749, 1997.

A. Rajakumar, K. A. Whitelock, L. A. Weissfeld, A. R. Daftary, N. Markovic et al., Selective overexpression of the hypoxia-inducible transcription factor, HIF-2alpha, in placentas from women with preeclampsia, Biol Reprod, vol.64, pp.499-506, 2001.

G. Masotti, G. Galanti, L. Poggesi, R. Abbate, N. Serneri et al., Differential inhibition of prostacyclin production and platelet aggregation by aspirin, Lancet, vol.2, pp.1213-1220, 1979.

F. Bussolino, C. Benedetto, M. Massobrio, and G. Camussi, Maternal vascular prostacyclin activity in pre-eclampsia, Lancet, vol.2, p.702, 1980.

D. Schlembach, W. Wallner, R. Sengenberger, E. Stiegler, M. Mörtl et al., Angiogenic growth factor levels in maternal and fetal blood: correlation with Doppler ultrasound parameters in pregnancies complicated by pre-eclampsia and intrauterine growth restriction, Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol, vol.29, pp.407-420, 2007.

M. Widmer, J. Villar, A. Benigni, A. Conde-agudelo, S. A. Karumanchi et al., Mapping the theories of preeclampsia and the role of angiogenic factors: a systematic review, Obstet Gynecol, vol.109, pp.168-80, 2007.

J. Espinoza, T. Chaiworapongsa, R. Romero, Y. M. Kim, G. J. Kim et al., Unexplained fetal death: another anti-angiogenic state, J Matern-Fetal Neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet, vol.20, pp.495-507, 2007.

A. M. Germain, M. C. Romanik, I. Guerra, S. Solari, M. S. Reyes et al., Endothelial dysfunction: a link among preeclampsia, recurrent pregnancy loss, and future cardiovascular events?, Hypertension, vol.49, pp.90-95, 2007.

S. Venkatesha, M. Toporsian, C. Lam, J. Hanai, T. Mammoto et al., Soluble endoglin contributes to the pathogenesis of preeclampsia, Nat Med, vol.12, pp.642-651, 2006.

R. J. Levine, C. Lam, C. Qian, K. F. Yu, S. E. Maynard et al., Soluble endoglin and other circulating antiangiogenic factors in preeclampsia, N Engl J Med, vol.355, pp.992-1005, 2006.

H. Stepan, T. Krämer, and R. Faber, Maternal plasma concentrations of soluble endoglin in pregnancies with intrauterine growth restriction, J Clin Endocrinol Metab, vol.92, pp.2831-2835, 2007.

A. G. Moore, H. Young, J. M. Keller, L. R. Ojo, J. Yan et al., Angiogenic biomarkers for prediction of maternal and neonatal complications in suspected preeclampsia, J MaternFetal Neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet, vol.25, pp.2651-2658, 2012.

R. W. Powers, A. Jeyabalan, R. G. Clifton, P. Van-dorsten, J. C. Hauth et al., Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies, PloS One, vol.5, p.13263, 2010.

S. Lisonkova and K. S. Joseph, Incidence of preeclampsia: risk factors and outcomes associated with early-versus late-onset disease, Am J Obstet Gynecol, vol.209, 2013.

E. Steegers, P. Von-dadelszen, J. J. Duvekot, and R. Pijnenborg, Pre-eclampsia, Lancet, vol.376, pp.631-675, 2010.

J. M. Roberts and J. M. Catov, Preeclampsia more than 1 disease: or is it? Hypertens Dallas Tex, vol.51, pp.989-90, 1979.

D. Wright, A. Syngelaki, R. Akolekar, L. C. Poon, and K. H. Nicolaides, Competing risks model in screening for preeclampsia by maternal characteristics and medical history, Am J Obstet Gynecol, vol.213, pp.62-63, 2015.

D. Gallo, L. C. Poon, M. Fernandez, D. Wright, and K. H. Nicolaides, Prediction of preeclampsia by mean arterial pressure at 11-13 and 20-24 weeks' gestation, Fetal Diagn Ther, vol.36, pp.28-37, 2014.

C. J. Fouché, E. G. Simon, and F. Perrotin,

, Gynecol Obstet Fertil, vol.40, pp.194-200, 2012.

T. Y. Khong, D. Wolf, F. Robertson, W. B. Brosens, and I. , Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants, Br J Obstet Gynaecol, vol.93, pp.1049-59, 1986.

M. A. Coleman, L. M. Mccowan, and R. A. North, Mid-trimester uterine artery Doppler screening as a predictor of adverse pregnancy outcome in high-risk women, Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol, vol.15, pp.7-12, 2000.

B. García, E. Llurba, L. Valle, M. D. Gómez-roig, M. Juan et al., Do knowledge of uterine artery resistance in the second trimester and targeted surveillance improve maternal and perinatal outcome? UTOPIA study: a randomized controlled trial

, Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol, vol.47, pp.680-689, 2016.

D. M. Gallo, L. C. Poon, R. Akolekar, A. Syngelaki, and K. H. Nicolaides, Prediction of preeclampsia by uterine artery Doppler at 20-24 weeks' gestation, Fetal Diagn Ther, vol.34, pp.241-248, 2013.

J. Lefebvre, S. Demers, E. Bujold, K. H. Nicolaides, M. Girard et al., Comparison of two different sites of measurement for transabdominal uterine artery Doppler velocimetry at 11-13 weeks, Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol, vol.40, pp.288-92, 2012.

P. M. Nowak, L. Nardozza, A. Júnior, E. Rolo, L. C. Moron et al., Comparison of placental volume in early pregnancy using multiplanar and VOCAL methods, Placenta, vol.29, pp.241-246, 2008.

E. Bujold, M. Effendi, M. Girard, K. Gouin, J. Forest et al., Reproducibility of first trimester three-dimensional placental measurements in the evaluation of early placental insufficiency, J Obstet Gynaecol Can JOGC J Obstétrique Gynécologie Can JOGC, vol.31, pp.1144-1152, 2009.

K. Deurloo, M. Spreeuwenberg, M. Rekoert-hollander, and J. Van-vugt, Reproducibility of 3-dimensional sonographic measurements of fetal and placental volume at gestational ages of 11-18 weeks, J Clin Ultrasound JCU, vol.35, pp.125-157, 2007.

S. Viero, V. Chaddha, F. Alkazaleh, M. J. Simchen, A. Malik et al., Prognostic value of placental ultrasound in pregnancies complicated by absent end-diastolic flow velocity in the umbilical arteries, Placenta, vol.25, pp.735-776, 2004.

T. Hata, H. Tanaka, J. Noguchi, and K. Hata, Three-dimensional ultrasound evaluation of the placenta, Placenta, vol.32, pp.105-120, 2011.

M. Toal, S. Keating, G. Machin, J. Dodd, S. L. Adamson et al., Determinants of adverse perinatal outcome in high-risk women with abnormal uterine artery Doppler images, Am J Obstet Gynecol, vol.198, pp.330-331, 2008.

N. Schwartz, E. Wang, and S. Parry, Two-dimensional sonographic placental measurements in the prediction of small-for-gestational-age infants, Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol, vol.40, pp.674-683, 2012.

P. Mcginty, N. Farah, V. O. Dwyer, J. Hogan, A. Reilly et al., Ultrasound assessment of placental function: the effectiveness of placental biometry in a low-risk population as a predictor of a small for gestational age neonate, Prenat Diagn, vol.32, pp.620-626, 2012.

K. B. Cheong, K. Y. Leung, T. Li, H. Y. Chan, Y. P. Lee et al., Comparison of inter-and intraobserver agreement and reliability between three different types of placental volume measurement technique (XI VOCAL, VOCAL and multiplanar) and validity in the in-vitro setting, Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol, vol.36, pp.210-217, 2010.

E. Hafner, M. Metzenbauer, D. Höfinger, M. Munkel, R. Gassner et al., Placental growth from the first to the second trimester of pregnancy in SGA-foetuses and preeclamptic pregnancies compared to normal foetuses, Placenta, vol.24, pp.336-378, 2003.

E. Hafner, M. Metzenbauer, D. Höfinger, F. Stonek, K. Schuchter et al., Comparison between three-dimensional placental volume at 12 weeks and uterine artery impedance/notching at 22 weeks in screening for pregnancy-induced hypertension, preeclampsia and fetal growth restriction in a low-risk population, Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol, vol.27, pp.652-659, 2006.

L. Nardozza, P. M. Nowak, A. Júnior, E. , G. Filho et al.,

, Placenta, vol.30, pp.585-594, 2009.

E. Hafner, T. Philipp, K. Schuchter, B. Dillinger-paller, K. Philipp et al., Second-trimester measurements of placental volume by three-dimensional ultrasound to predict small-forgestational-age infants, Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol, vol.12, pp.97-102, 1998.

E. Hafner, K. Schuchter, M. Van-leeuwen, M. Metzenbauer, B. Dillinger-paller et al., Three-dimensional sonographic volumetry of the placenta and the fetus between weeks 15 and 17 of gestation, Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol, vol.18, pp.116-136, 2001.

C. De-paula, R. Ruano, J. Campos, and M. Zugaib, Placental volumes measured by 3-dimensional ultrasonography in normal pregnancies from 12 to 40 weeks' gestation, J Ultrasound Med Off J Am Inst Ultrasound Med, vol.27, pp.1583-90, 2008.

K. M. Huster, K. Haas, J. Schoenborn, D. Mcvean, and A. O. Odibo, Reproducibility of placental volume and vasculature indices obtained by 3-dimensional power Doppler sonography, J Ultrasound Med Off J Am Inst Ultrasound Med, vol.29, pp.911-917, 2010.

Y. Zhong, M. Tuuli, and A. O. Odibo, First-trimester assessment of placenta function and the prediction of preeclampsia and intrauterine growth restriction, Prenat Diagn, vol.30, pp.293-308, 2010.

M. Thame, C. Osmond, F. Bennett, R. Wilks, and T. Forrester, Fetal growth is directly related to maternal anthropometry and placental volume, Eur J Clin Nutr, vol.58, pp.894-900, 2004.

M. Thame, C. Osmond, R. Wilks, F. I. Bennett, and T. E. Forrester, Second-trimester placental volume and infant size at birth, Obstet Gynecol, vol.98, pp.279-83, 2001.

E. Hafner, M. Metzenbauer, B. Dillinger-paller, D. Hoefinger, K. Schuchter et al., Correlation of first trimester placental volume and second trimester uterine artery Doppler flow, Placenta, vol.22, pp.729-763, 2001.

L. K. Proctor, M. Toal, S. Keating, D. Chitayat, N. Okun et al., Placental size and the prediction of severe early-onset intrauterine growth restriction in women with low pregnancy-associated plasma protein-A, Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol, vol.34, pp.274-82, 2009.

N. Schwartz, J. Coletta, C. Pessel, R. Feng, I. E. Timor-tritsch et al., Novel 3-dimensional placental measurements in early pregnancy as predictors of adverse pregnancy outcomes, J Ultrasound Med Off J Am Inst Ultrasound Med, vol.29, pp.1203-1215, 2010.

K. Schuchter, M. Metzenbauer, E. Hafner, and K. Philipp, Uterine artery Doppler and placental volume in the first trimester in the prediction of pregnancy complications, Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol, vol.18, pp.590-592, 2001.

G. Rizzo, A. Capponi, O. Cavicchioni, M. Vendola, and D. Arduini,

, Eur J Obstet Gynecol Reprod Biol, vol.138, pp.147-51, 2008.

M. Metzenbauer, E. Hafner, D. Hoefinger, K. Schuchter, G. Stangl et al., Threedimensional ultrasound measurement of the placental volume in early pregnancy: method and correlation with biochemical placenta parameters, Placenta, vol.22, pp.602-607, 2001.

S. L. Costa, L. Proctor, J. M. Dodd, M. Toal, N. Okun et al., Screening for placental insufficiency in high-risk pregnancies: is earlier better?, Placenta, vol.29, pp.1034-1074, 2008.

J. Duan, C. Perdriolle-galet, E. Christov, C. Hossu, G. Cherifi et al., Utero-placental vascularisation in normal and preeclamptic and intra-uterine growth restriction pregnancies: third trimester quantification using 3D power Doppler with comparison to placental vascular morphology (EVUPA): a prospective controlled study, BMJ Open, vol.6, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01737058

J. Costa, H. Rice, C. Cardwell, A. Hunter, and S. Ong, An assessment of vascularity and flow intensity of the placenta in normal pregnancy and pre-eclampsia using three-dimensional ultrasound, J Matern-Fetal Neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet, vol.23, pp.894-903, 2010.

P. Dar, J. Gebb, L. Reimers, P. S. Bernstein, C. Chazotte et al., First-trimester 3-dimensional power Doppler of the uteroplacental circulation space: a potential screening method for preeclampsia, Am J Obstet Gynecol, vol.203, pp.238-239, 2010.

E. Hafner, M. Metzenbauer, I. Stümpflen, T. Waldhör, and K. Philipp, First trimester placental and myometrial blood perfusion measured by 3D power Doppler in normal and unfavourable outcome pregnancies, Placenta, vol.31, pp.756-63, 2010.

S. Vieillefosse, J. Guibourdenche, A. Atallah, B. Haddad, T. Fournier et al.,

, J Gynecol Obstet Biol Reprod (Paris), vol.45, pp.999-1008, 2016.

S. Rana, C. E. Powe, S. Salahuddin, S. Verlohren, F. H. Perschel et al., Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia, Circulation, vol.125, pp.911-920, 2012.

S. Rana, A. S. Cerdeira, J. Wenger, S. Salahuddin, K. Lim et al., Plasma Concentrations of Soluble Endoglin versus Standard Evaluation in Patients with Suspected Preeclampsia, PLoS ONE, vol.7, 2012.

S. Verlohren, I. Herraiz, O. Lapaire, D. Schlembach, H. Zeisler et al., New Gestational Phase-Specific Cutoff Values for the Use of the Soluble fms-Like Tyrosine Kinase-1/Placental Growth Factor Ratio as a Diagnostic Test for Preeclampsia, Hypertension, 2013.

S. Verlohren, I. Herraiz, O. Lapaire, D. Schlembach, M. Moertl et al., The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients, Am J Obstet Gynecol, vol.206, pp.58-59, 2012.

H. Zeisler, E. Llurba, F. Chantraine, M. Vatish, A. C. Staff et al., Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia, N Engl J Med, vol.374, pp.13-22, 2016.

S. Salahuddin, Y. Lee, M. Vadnais, B. P. Sachs, S. A. Karumanchi et al., Diagnostic utility of soluble fms-like tyrosine kinase 1 and soluble endoglin in hypertensive diseases of pregnancy, Am J Obstet Gynecol, vol.197, pp.28-29, 2007.

J. P. Kusanovic, R. Romero, T. Chaiworapongsa, O. Erez, P. Mittal et al., A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia, J Matern-Fetal Neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet, vol.22, pp.1021-1059, 2009.

C. E. Kleinrouweler, M. Wiegerinck, C. Ris-stalpers, P. Bossuyt, J. Van-der-post et al., Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis, BJOG Int J Obstet Gynaecol, vol.119, pp.778-87, 2012.

M. Simas, T. A. Crawford, S. L. Solitro, M. J. Frost, S. C. Meyer et al., Angiogenic factors for the prediction of preeclampsia in high-risk women, Am J Obstet Gynecol, vol.197, pp.244-245, 2007.

M. Simas, T. A. Crawford, S. L. Bathgate, S. Yan, J. Robidoux et al., Angiogenic biomarkers for prediction of early preeclampsia onset in high-risk women, J Matern-Fetal Neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet, 2013.

S. E. Maynard, S. L. Crawford, S. Bathgate, J. Yan, L. Robidoux et al., Gestational angiogenic biomarker patterns in high risk preeclampsia groups, Am J Obstet Gynecol, vol.209, pp.53-54, 2013.

L. Poon, N. A. Kametas, N. Maiz, R. Akolekar, and K. H. Nicolaides, First-trimester prediction of hypertensive disorders in pregnancy. Hypertens Dallas Tex, vol.53, pp.812-820, 1979.

N. O'gorman, D. Wright, A. Syngelaki, R. Akolekar, A. Wright et al., Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation, Am J Obstet Gynecol, vol.214, pp.103-104, 2016.

D. M. Gallo, D. Wright, C. Casanova, M. Campanero, and K. H. Nicolaides, Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19-24 weeks' gestation, Am J Obstet Gynecol, vol.214, pp.619-620, 2016.

A. Tsiakkas, Y. Saiid, A. Wright, D. Wright, and K. H. Nicolaides, Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 30-34 weeks' gestation

, Am J Obstet Gynecol, vol.215, pp.87-88, 2016.

N. O'gorman, K. H. Nicolaides, and L. Poon, The use of ultrasound and other markers for early detection of preeclampsia, Womens Health Lond Engl, vol.12, issue.2, pp.199-207, 2016.

N. Oliveira, L. S. Magder, M. G. Blitzer, and A. A. Baschat, First-trimester prediction of preeclampsia: external validity of algorithms in a prospectively enrolled cohort, Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol, vol.44, pp.279-85, 2014.

D. Subtil, P. Goeusse, F. Puech, P. Lequien, S. Biausque et al., Aspirin (100 mg) used for prevention of pre-eclampsia in nulliparous women: the Essai Régional Aspirine Mère-Enfant study (Part 1), BJOG Int J Obstet Gynaecol, vol.110, pp.475-84, 2003.

M. Knight, L. Duley, D. J. Henderson-smart, and J. F. King, Antiplatelet agents for preventing and treating pre-eclampsia, Cochrane Database Syst Rev, p.492, 2000.

L. Duley, D. J. Henderson-smart, S. Meher, and J. F. King, Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev Online, p.4659, 2007.

L. M. Askie, L. Duley, D. J. Henderson-smart, and L. A. Stewart, Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data, Lancet, vol.369, pp.1791-1799, 2007.

B. Brenner, R. Hoffman, Z. Blumenfeld, Z. Weiner, and J. S. Younis, Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin, Thromb Haemost, vol.83, pp.693-700, 2000.

B. Brenner, J. Bar, M. Ellis, I. Yarom, D. Yohai et al., Effects of enoxaparin on late pregnancy complications and neonatal outcome in women with recurrent pregnancy loss and thrombophilia: results from the Live-Enox study, Fertil Steril, vol.84, pp.770-773, 2005.

B. Brenner, R. Hoffman, H. Carp, M. Dulitsky, J. Younis et al., Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study, J Thromb Haemost JTH, vol.3, pp.227-236, 2005.

J. M. Dodd, A. Mcleod, R. C. Windrim, and J. Kingdom, Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction

, Cochrane Database Syst Rev, p.6780, 2010.

J. M. Dodd, A. Mcleod, R. C. Windrim, and J. Kingdom, Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction

, Cochrane Database Syst Rev, vol.7, p.6780, 2013.

B. Haddad, N. Winer, Y. Chitrit, V. Houfflin-debarge, C. Chauleur et al., Enoxaparin and Aspirin Compared With Aspirin Alone to Prevent Placenta-Mediated Pregnancy Complications: A Randomized Controlled Trial, Obstet Gynecol, vol.128, pp.1053-63, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01900637

D. Subtil, P. Goeusse, V. Houfflin-debarge, F. Puech, P. Lequien et al., Randomised comparison of uterine artery Doppler and aspirin (100 mg) with placebo in nulliparous women: the Essai Régional Aspirine Mère-Enfant study (Part 2), BJOG Int J Obstet Gynaecol, vol.110, pp.485-91, 2003.

D. L. Rolnik, D. Wright, L. C. Poon, N. O'gorman, A. Syngelaki et al., Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia, N Engl J Med, 2017.

M. Torricelli, F. M. Reis, P. Florio, F. M. Severi, C. Bocchi et al., Lowmolecular-weight heparin improves the performance of uterine artery Doppler velocimetry to predict preeclampsia and small-for-gestational age infant in women with gestational hypertension, Ultrasound Med Biol, vol.32, pp.1431-1436, 2006.

Y. Yu, L. Shen, M. Zhong, Y. Zhang, G. Su et al.,

, Zhonghua Fu Chan Ke Za Zhi, vol.39, pp.793-799, 2004.

E. Lefkou, A. Mamopoulos, T. Dagklis, C. Vosnakis, D. Rousso et al., Pravastatin improves pregnancy outcomes in obstetric antiphospholipid syndrome refractory to antithrombotic therapy, J Clin Invest, vol.126, pp.2933-2973, 2016.

E. W. Seely, G. H. Williams, and S. W. Graves, Markers of sodium and volume homeostasis in pregnancy-induced hypertension, J Clin Endocrinol Metab, vol.74, pp.150-156, 1992.

D. P. Cruikshank, G. M. Chan, and D. Doerrfeld, Alterations in vitamin D and calcium metabolism with magnesium sulfate treatment of preeclampsia, Am J Obstet Gynecol, vol.168, pp.1170-1176, 1993.

L. M. Bodnar, J. M. Catov, H. N. Simhan, M. F. Holick, R. W. Powers et al., Maternal vitamin D deficiency increases the risk of preeclampsia, J Clin Endocrinol Metab, vol.92, pp.3517-3539, 2007.